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Clinics and pathology 
Disease 
Chronic T-cell lymphoproliferative syndrome. 
Phenotype/cell stem origin 
Disease affecting mature T-cells; T-cell 
prolymphocytes usually express CD3, CD5 and CD7; 
they have either a T-helper (CD4+/CD8-) or a T-
suppressor (CD4-/CD8+) phenotype; a small number of 
cases may co-express CD4 and CD8; this finding is 
more prevalent in the small cell variant of T-PLL than 
in classic T-PLL. 
Epidemiology 
Very rare disease; represents 20% of prolymphocytic 
leukemias; the disease occurs at advanced age, 
typically in the 7th or 8th decade; slight male 
predominance. 
Clinics 
Splenomegaly is common; lymphadenopathy at 
presentation is unusual but more frequent than in B-
PLL; blood data: high leucocyte counts usually 
exceeding 100x109/l; T-cell prolymphocytes have the 
same morphologic features than B-cell 
prolymphocytes; a small cell variant of T-PLL has been 
described. 
Prognosis 
Evolution: progresses rapidly and is generally more 
aggressive than B-PLL; prognosis: poor response to 
chemotherapy is observed; median survival is 





Few cases have been reported in the literature. 
So far; karyotypes are usually complex. 
14q11 abnormalities: very frequent, either as an 
inv(14)(q11q32) or as a translocation 
t(14;14)(q11;q32); another reported change involving 
14q11 is a translocation t(X;14)(q28;q11), similar to 
the translocation observed in ataxia-telangectasia, 
involving the Mature T-cell Prolymphocyte 1 (MTCP1) 
gene located at Xq28. 
Other recurrent changes involve chromosome 8 either 
as i(8)(q10) or as der(8) t(8;8). 
Finally, some aberrations involving 12p have been 
reported. 
Genes involved and proteins 
Note 
As with other T-cell neoplasms, T-PLL exhibits clonal 
rearrangement of T-cell receptor genes; translocatin 
t(X;14)(q28;q11) may result into fusion of MTCP1 
with TRA/D genes; finally, the TCL1 locus on 
chromosome 14q32 might also been involved. 
In Ataxia Telangiectasia- a rare recessive pleiotropic 
disease (including elevated cancer predisposition) 
mapping to 11q23 and caused by mutations of theATM 
gene - a recurrent malignancy is observed that is 
similar to T-PLL; its frequency in A-T patients is 
higher than in the non-A-T related form; A-T related 
TPLL has a similar course, a similar immunophenotype 
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that 11q23 breakpoints are recurrent in the sporadic but  
not the A-T related form of the disease); an initial 
report of ATM mutations in T-PLL demonstrated the 
principle that ATM was a candidate cancer gene in 
sporadic forms of malignancies prevalent in A-T; the 
identification of lesions in ATM associated with T-PLL 
has shown that: 
Homozygous truncating mutations are present in some 
cases; this suggests ATM can appear to act like a 
conventional tumour suppressor with biallelic 
inactivation in the tumour cell. 
Missense mutations cluster in the carboxy-terminal 
phosphatidyl-3-kinase (PIK) domain; this suggests 
impairment of this domain can contribute to - and may 
constitute a distinct step in – tumourigenesis. 
Rearrangement of the gene is frequent; some 
rearrangements are consistent with a translocation 
event, in agreement with cytogenetic data implicating 
11q23 in T-PLL; others involve transposition of a 
segment of the ATM gene elsewhere in the genome. 
One allele only is mutated (by rearrangement) in some 
cases; this is probably not associated with a 
concomitant epigenetic event such as abnormal 
promoter methylation. 
No T-PLL case has been reported with germline ATM 
mutation; this may reflect the small numbers 
investigated; all the same, the hypothesis is excluded 
that this rare disease is due solely to germline ATM 
mutation. 
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